Cystic Fibrosis Trial, Recruiting (NCT04700358)

Cystic Fibrosis Trial, Recruiting NCT04700358 Sponsor: University Hospital of Cologne Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT04700358 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who are able to give their own consent to participate
People with a blood pressure reading within a normal range (top number between 100–150, bottom number below 90)
People with a breathing rate of fewer than 20 breaths per minute
People with a blood oxygen level above 92%
People with a heart rate between 50 and 110 beats per minute
People with a body temperature below 38°C

Who may not be able to join:

People with low blood cell counts, including low white blood cells, low platelets, or low haemoglobin (a measure of red blood cells)
People with a heart condition or high blood pressure in the lungs
People who weigh less than 50 kg
People who have donated blood, had significant blood loss, or undergone major surgery in the past 8 weeks (for men) or 12 weeks (for women)
People who have experienced a general decline in their health in the past 3 months, including losing more than 2 kg in weight, a lung flare-up, or a significant drop in lung function (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Silke van Koningsbruggen-Rietschel, MD, PhD, University Hospital Cologne

Phone: +4922147889608

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04700358

Sponsor: University Hospital of Cologne

Phase: Not Applicable

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: +4922147889608

More information: https://clinicaltrials.gov/study/NCT04700358

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who are able to give their own consent to participate
People with a blood pressure reading within a normal range (top number between 100–150, bottom number below 90)
People with a breathing rate of fewer than 20 breaths per minute
People with a blood oxygen level above 92%
People with a heart rate between 50 and 110 beats per minute
People with a body temperature below 38°C

Who may not be able to join:

People with low blood cell counts, including low white blood cells, low platelets, or low haemoglobin (a measure of red blood cells)
People with a heart condition or high blood pressure in the lungs
People who weigh less than 50 kg
People who have donated blood, had significant blood loss, or undergone major surgery in the past 8 weeks (for men) or 12 weeks (for women)
People who have experienced a general decline in their health in the past 3 months, including losing more than 2 kg in weight, a lung flare-up, or a significant drop in lung function (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital of Cologne

Registry

ClinicalTrials.gov

Start date

1 October 2020

Est. completion

30 September 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Prevalence of antibacterial antibodies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov